AVITA Medical, Inc.
Company Stats
- Market Cap
- $362.8M
- as of Sep 30, 2026
- Enterprise Value
- $392.5M
- Shares Outstanding
- 30.9M
- Free Float
- 97.8%
Income Statement
- Revenue
- $70.9M
- Operating Income
- -$42.5M
- Net Income
- -$48.6M
- EBITDA
- -$40.2M
- Revenue Growth, 3Y
- 27.2%
- FCF Margin, 3Y Avg
- -71.6%
- FCF Margin, Worst Year
- -90.9%
Cash Flow
- Free Cash Flow
- -$32.2M
- FCF Yield
- -8.9%
- Owner FCF Yield
- -11.5%
Balance Sheet
- Cash & Equivalents
- $10.2M
- Total Debt
- $40.0M
- Net Debt
- $29.8M
Returns & Capital
- SBC, 3Y Avg
- $10.5M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $70.9M | -$32.2M | -45.4% |
| FY2024 | $63.9M | -$58.1M | -90.9% |
| FY2023 | $50.1M | -$39.4M | -78.6% |
| FY2022 | $34.4M | -$19.5M | -56.8% |
Annual filing data through FY ended December 31, 2025; shares and float as of November 4, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges